APA (7th ed.) Citation

Song, J. H., Hong, S. N., Kim, M. G., Kim, M., Kim, S. K., Kim, E. R., . . . Kim, Y. Population Pharmacokinetic Model for the Use of Intravenous or Subcutaneous Infliximab in Patients with Inflammatory Bowel Disease: Real-World Data from a Prospective Cohort Study. Gastroenterology Council for Gut and Liver.

Chicago Style (17th ed.) Citation

Song, Joo Hye, Sung Noh Hong, Myeong Gyu Kim, Minjung Kim, Seong Kyung Kim, Eun Ran Kim, Dong Kyung Chang, and Young-Ho Kim. Population Pharmacokinetic Model for the Use of Intravenous or Subcutaneous Infliximab in Patients with Inflammatory Bowel Disease: Real-World Data from a Prospective Cohort Study. Gastroenterology Council for Gut and Liver.

MLA (9th ed.) Citation

Song, Joo Hye, et al. Population Pharmacokinetic Model for the Use of Intravenous or Subcutaneous Infliximab in Patients with Inflammatory Bowel Disease: Real-World Data from a Prospective Cohort Study. Gastroenterology Council for Gut and Liver.